Position in NVO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,594,867
+$372,268 QoQ
Shares Held
33,268
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#423
of 1,348 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. NVO ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,594,867 | 33,268 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,222,599 | 33,268 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,845,315 | 36,268 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,012,511 | 36,268 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,503,217 | 36,268 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,518,449 | 36,268 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,119,773 | 36,268 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||